[Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
D000368:Aged; D002262:Carboxy-Lyases / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*
D004338:Drug Combinations; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Kombinationsbehandlung des Parkinson-Syndroms mit L-Dopa und einem Decarboxylasehemmer.